AzTrials
AzTrials

Pulp NecrosesPhase 2NCT06129643

"Postoperative Pain Following Laser-Assisted Root Canal Treatment: A Randomized Clinical Trial"

A Phase 2 study testing Conventional group, Dual laser group and Combined group in people with Pulp Necroses and Apical Periodontitis, run by Future University in Egypt at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate in vivo the post operative pain after laser root canal treatment in necrotic teeth in an evidence-based clinical trial. The null hypothesis being tested is that there is no difference in post operative pain between conventional irrigation and the two types of lasers used. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
What is being tested?
Conventional group, Dual laser group and Combined group
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteEgypt
Study dates
1 Jan 2022to 1 Feb 2023
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients who had asymptomatic, single-rooted maxillary anterior teeth with necrotic pulp and periapical lesion with a periapical index score of 3 or 4
  • Patients complaining of no pain and without fistulous tract
  • Closed apex.
  • Acceptance to participate in the study.

Who cannot join

  • Antibiotic use within the last month, anti-inflammatory analgesic use within the last 5 d, systemic diseases or allergic reactions, calcified canals, root resorption, previous root canal treatment.
  • Periodontal diseases, presence of swelling or fistulous tract.
  • Vulnerable group including pregnant females, mentally or physically disabled individuals. - Technical difficulties during root canal treatment such as; curved roots, broken files, over instrumentation, overfilling or incomplete filling.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ain Shams University

    Cairo, Abbassia, 11566

Other trials in Egypt

About this study

Official title: "Postoperative Pain Following Laser-Assisted Root Canal Treatment of Necrotic Teeth With Apical Periodontitis: A Randomized Clinical Trial"

The aim of this study is to evaluate in vivo the post operative pain after laser root canal treatment in necrotic teeth in an evidence-based clinical trial. The null hypothesis being tested is that there is no difference in post operative pain between conventional irrigation and the two types of lasers used.

Forty-five patients are equally divided into 3 separate groups :

  • Group A (Conventional): 2.5% NaOCL and 17% EDTA.
  • Group B(Dual): saline along with Er,Cr:YSGG laser and diode laser combination
  • Group C(Combined): saline along with 17% EDTA and diode laser combination Each patient is given pain scale chart Numeric Rating Scale (NRS) to record his/her pain level before any endodontic treatment. All data will be collected, tabulated, summarized, and statistically analyzed.
Read the detailed description

Postoperative pain is a common complication following conventional endodontic treatment. According to a systematic review, the frequency of endodontic postoperative pain is between 3% and 58% of patients.Postoperative pain is attributed to chemical, mechanical and microbiological factors.

Residual microorganisms remaining due to the complexity of the root canal system and the limited penetration capability of conventional irrigants are directly responsible for Post operative pain The aim of this study is to evaluate in vivo the post operative pain after laser root canal treatment in necrotic teeth in an evidence-based clinical trial. The null hypothesis being tested is that there is no difference in post operative pain between conventional irrigation and the two types of lasers used.

Forty-five patients are equally divided into 3 separate groups :

  • Group A (Conventional): 2.5% NaOCL and 17% EDTA.
  • Group B(Dual): saline along with Er,Cr:YSGG laser and diode laser combination
  • Group C(Combined): saline along with 17% EDTA and diode laser combination Each patient will be given pain scale chart (NRS scale) to record his/her pain level before any endodontic treatment. After disinfection, local anesthetic, tooth isolation, access cavity preparation and final obturation. Patients are asked to mark on a numeric rating scale (NRS) to determine incidence of postoperative pain and rate its intensity at 6, 12, 24, 48, 72 hours, and 7 days after the procedure All data will be collected, tabulated, summarized, and statistically analyzed.
Being tested
Conventional group, Dual laser group, Combined group
Keywords
laser in endodontics, post-operative pain
Medical subject headings
Dental Pulp Necrosis, Periapical Periodontitis, Dental Pulp Diseases, Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional groupDrug

    Also called (NaOCl/EDTA)

    conventional disinfection using 2.5% sodium hypochlorite and 17% EDTA

  • Dual laser groupDevice

    Also called (Er,Cr:YSGG/Diode)

    Er,Cr:YSGG intracanal laser irradiation to remove smear layer followed by diode laser for disinfection

  • Combined groupCombination product

    Also called (EDTA/Diode)

    17% EDTA was used to remove smear layer followed by diode laser for disinfection

Study groups in NCT06129643
Study groupRoleWhat they receive
Conventional group AActive comparatorNot described
Receives: Drug: Conventional group
Dual laser group (Er,Cr:YSGG/Diode)ExperimentalNot described
Receives: Device: Dual laser group
Combined group (EDTA/Diode):ExperimentalNot described
Receives: Combination Product: Combined group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pain assessment

    Patients will be asked to mark Numeric rating scale (NRS) to determine incidence of postoperative pain and rate its intensity. The NRS consisted of a line anchored by two extremes "No pain" and "the worst pain".

    • Pain level assigned to one of 4 categorical scores:
    • No pain (0), Mild (1-3), Moderate (4-6) and Severe (7-10).

    Measured: Measure changes in post-operative pain 6 hours after intervention in the three groups using NRS

  2. Postoperative pain assessment

    Patients will be asked to mark Numeric rating scale (NRS) to determine incidence of postoperative pain and rate its intensity. The NRS consisted of a line anchored by two extremes "No pain" and "the worst pain".

    • Pain level assigned to one of 4 categorical scores:
    • No pain (0), Mild (1-3), Moderate (4-6) and Severe (7-10).

    Measured: Measure changes in post-operative pain 12 hours after intervention in the three groups using NRS

  3. Postoperative pain assessment

    Patients will be asked to mark Numeric rating scale (NRS) to determine incidence of postoperative pain and rate its intensity. The NRS consisted of a line anchored by two extremes "No pain" and "the worst pain".

    • Pain level assigned to one of 4 categorical scores:
    • No pain (0), Mild (1-3), Moderate (4-6) and Severe (7-10).

    Measured: Measure changes in post-operative pain 24 hours after intervention in the three groups using NRS

  4. Postoperative pain assessment

    Patients will be asked to mark Numeric rating scale (NRS) to determine incidence of postoperative pain and rate its intensity. The NRS consisted of a line anchored by two extremes "No pain" and "the worst pain".

    • Pain level assigned to one of 4 categorical scores:
    • No pain (0), Mild (1-3), Moderate (4-6) and Severe (7-10).

    Measured: Measure changes in post-operative pain 48 hours after intervention in the three groups using NRS

  5. Postoperative pain assessment

    Patients will be asked to mark Numeric rating scale (NRS) to determine incidence of postoperative pain and rate its intensity. The NRS consisted of a line anchored by two extremes "No pain" and "the worst pain".

    • Pain level assigned to one of 4 categorical scores:
    • No pain (0), Mild (1-3), Moderate (4-6) and Severe (7-10).

    Measured: Measure changes in post-operative pain 72 hours after intervention in the three groups using NRS

  6. Postoperative pain assessment

    Patients will be asked to mark Numeric rating scale (NRS) to determine incidence of postoperative pain and rate its intensity. The NRS consisted of a line anchored by two extremes "No pain" and "the worst pain".

    • Pain level assigned to one of 4 categorical scores:
    • No pain (0), Mild (1-3), Moderate (4-6) and Severe (7-10).

    Measured: Measure changes in post-operative pain up to 7 days after intervention in the three groups using NRS

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Nov 2023
  2. Study start1 Jan 2022
  3. Primary completion30 Oct 2022
  4. Study completion1 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06129643
Sponsor's protocol ID
FDASU-Rec ID 041909
Status last verified
Jun 2026
First submitted
8 Nov 2023
Last updated
30 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Conventional group, Dual laser group and Combined group in people with Pulp Necroses and Apical Periodontitis, run by Future University in Egypt at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pain assessment (time frame: Measure changes in post-operative pain 6 hours after intervention in the three groups using NRS). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in